Trump's remarks came a day before the Fed was set to announce its next decision on interest rates.Politicsread more
But a look at state-by-state data clarifies the scale of Trump's challenge. As the president tries to rally supporters at a 2020 kickoff rally in Orlando on Tuesday, he is...Politicsread more
A Bloomberg News report Tuesday morning said the White House had looked at such a move in February.Marketsread more
The order for 200 737 Max jets from British Airways parent IAG was a vote of confidence for Boeing's beleaguered aircraft following two fatal crashes.Airlinesread more
June 10 (Reuters) - The U.S. Food and Drug Administration granted accelerated approval to Roche Holding AG's combo lymphoma treatment for previously treated patients, the company said on Monday
The drug, Polivy, is used in combination with Rituxan to treat an aggressive form of the disease.
The FDA's accelerated approval program allows conditional approval of a medicine that fills an unmet medical need for a serious condition, Roche said. (Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Anil D'Silva)